News: Suppliers
4 May 2021
Epiluvac appoints VP sales & marketing
Epiluvac AB of Lund, Sweden – which was founded in 2013 and makes chemical vapor deposition (CVD) equipment for wide-bandgap semiconductors –says that Dr Michael MacMillan has joined the company as VP of sales & marketing, based at its new office in Orange County, CA, USA.
“We see a growing demand for the next-generation CVD equipment, not only for silicon carbide (SiC) but also for gallium nitride (GaN),” notes Bo Hammarlund, board director, business development. “Mike’s expertise in SiC epitaxy, together with his long experience from both research and manufacturing companies, will certainly bring exciting benefits to our products and also our customers,” he believes.
Picture: Epiluvac’s new VP of sales & marketing Dr Michael MacMillan.
MacMillan was recently chief epitaxial scientist at SemiQ (formerly Global Power Technologies Group) of Lake Forest, CA, USA,and his career spans from early SiC research at Linköping University, Sweden in the 1990s to many years as leader and SiC scientist in major US companies such as Northrop Grumman and Dow Corning. He holds a PhD in Physics from University of Pittsburgh.
“This is a great opportunity and privilege to be part of this highly skilled team with their new, exciting CVD platform for wide-bandgap semiconductors,” comments MacMillan.
Epiluvac recently introduced a new product generation, primarily intended for SiC and GaN epitaxy. The new WBG-Multi-Reactor-CVD systems are based on hot-wall CVD and single-wafer processing of up to 200mm (8”)-diameter wafers, with an option to connect multiple chambers and wafer handling robots together in a cluster tool configuration to meet each customer’s requirement for higher output, flexibility or stepwise wafer processing through multiple chambers. Epiluvacs’s products are sold worldwide, either directly or through local partners.
Epiluvac supplies CVD reactors to Polish institute
Sweden's Epiluvac launches as manufacturer of SiC CVD equipment
